Article info

other Versions

PDF

Long-term treatment of patients with idiopathic pulmonary fibrosis with nintedanib: results from the TOMORROW trial and its open-label extension

Authors

  1. Correspondence to Professor Luca Richeldi, National Institute for Health Research Southampton Respiratory Biomedical Research Unit and Clinical and Experimental Sciences, University of Southampton, Southampton SO17 1BJ, UK; luca.richeldi{at}me.com
View Full Text

Citation

Richeldi L, Kreuter M, Selman M, et al
Long-term treatment of patients with idiopathic pulmonary fibrosis with nintedanib: results from the TOMORROW trial and its open-label extension

Publication history

  • Received November 9, 2016
  • Revised July 19, 2017
  • Accepted July 31, 2017
  • First published October 9, 2017.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.